Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st February, 2020 on account of Mahashivratri.

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

Free Report: The Biggest Wealth Creating Opportunity in India. Download Now...

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 675.00 4.95% 675.00 4.88%
 More Info 
AJANTA PHARMA 1,454.85 10.70% 1,451.00 10.42%
 More Info 
ALEMBIC PHARMA 664.80 -0.98% 664.70 -1.47%
 More Info 
BIOCON 315.00 2.92% 315.25 2.99%
 More Info 
CADILA HEALTHCARE 279.50 1.18% 279.00 1.12%
 More Info 
CIPLA 436.85 -2.37% 436.80 -2.39%
 More Info 
DIVIS LABORATORIES 2,168.95 -0.72% 2,172.00 -0.63%
 More Info 
DR. REDDYS LAB 3,255.50 -0.65% 3,257.00 -0.65%
 More Info 
GLENMARK PHARMA 322.70 1.51% 322.30 1.32%
 More Info 
INDOCO REMEDIES 267.35 2.73% 267.00 2.91%
 More Info 
IPCA LABS 1,458.50 3.60% 1,453.00 3.57%
 More Info 
J.B.CHEMICALS 536.50 0.66% 533.05 -0.36%
 More Info 
LUPIN 698.00 -1.53% 698.80 -1.45%
 More Info 
NATCO PHARMA 662.55 2.78% 666.00 3.30%
 More Info 
NIFTY 50 Not Listed 12,083.70 -0.35%
 More Info 
ORCHID PHARMA LTD 5.25 -4.89% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 115.90 -0.86% 116.70 0.17%
 More Info 
PIRAMAL ENTERPRISES 1,601.80 1.90% 1,600.20 1.72%
 More Info 
S&P BSE SENSEX 41,170.12 -0.37% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 514.50 1.82% 514.50 1.83%
 More Info 
SUN PHARMA 404.50 0.31% 404.80 0.31%
 More Info 
TORRENT PHARMA 2,240.00 -0.07% 2,235.00 -0.32%
 More Info 
WOCKHARDT 359.25 -2.30% 358.55 -2.50%
 More Info 

BSE prices: February 20, 2020  03:37:00 PM    NSE prices: February 20, 2020  3:30:00 PM

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,366.4 (down 0.2%). The index is down 18.8% over the last 30 days. And over the last 1 year, it has lost 10.9%.

Within the Indian Pharma sector, the top gainers were AJANTA PHARMA (up 10.7%) and AARTI DRUGS (up 5.0%). On the other hand, CIPLA (down 2.4%) and WOCKHARDT (down 2.3%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 12,083.7 (down 0.4%).




Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Related Views on News

AJANTA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Feb 20, 2020 | Updated on Feb 20, 2020

AJANTA PHARMA share price has surged by 13% and its current market price is Rs 1,485. The BSE HEALTHCARE is up by 0.3%. The top gainers in the BSE HEALTHCARE Index is AJANTA PHARMA (up 12.9%). The top losers are TORRENT PHARMA (down 0.2%) and SYNGENE INTERNATIONAL (down 0.2%).

FDC LTD. Surges by 5%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Feb 20, 2020 | Updated on Feb 20, 2020

FDC LTD. share price has surged by 5% and its current market price is Rs 254. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index are FDC LTD. (up 5.4%) and AJANTA PHARMA (up 7.4%). The top losers are GSK PHARMA (down 0.1%) and ALEMBIC PHARMA (down 0.2%).

GLENMARK PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 64.0% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 64.0% YoY). Sales on the other hand came in at Rs 27 bn (up 7.1% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

CoronaVirus' Impact on Indian Markets - And One Stock With the Potential to Make Crores... (Profit Hunter)

Feb 7, 2020

Even as the experts come to grips with impact of Coronavirus contagion on Indian stocks and economy, here's a stock not just immune to macro threats, but with the potential to offer crores in the long term.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

A Megatrend to Help You Find the Best Stocks of the Next Decade (The 5 Minute Wrapup)

Feb 12, 2020

Recent events have put climate change into the spotlight. Here's how you should play this megatrend...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Feb 20, 2020 03:37 PM

COMPARE COMPANY

MARKET STATS